|
Volumn 12, Issue 15, 2004, Pages 4221-4231
|
New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7β-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2- ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1- pyridinium at C-3′
|
Author keywords
[No Author keywords available]
|
Indexed keywords
(2 PYRIDIN 4 YLETHYL)CARBAMIC ACID TERT BUTYL ESTER;
(2 TERT BUTOXYCARBONYLAMINOETHYL)PYRIDIN 4 YLCARBAMIC ACID TERT BUTYL ESTER;
(3 TERT BUTOXYCARBONYLAMINOPROPYL)PYRIDIN 4 YLCARBAMIC ACID TERT BUTYL ESTER;
1 [2 (1,3 DIOXO 1,3 DIHYDROISOINDOL 2 YL)ETHYL] 3 PYRIDIN 4 YLUREA;
1 [2 N,N' BIS(TERT BUTOXYCARBONYL)GUANIDINOETHYL] 3 PYRIDIN 4 YLUREA;
1 [3 N,N' BIS(TERT BUTOXYCARBONYL)GUANIDINOPROPYL] 3 PYRIDIN 4 YLUREA;
3 (3 PYRIDIN 4 YLUREIDO)PYRROLIDINE 1 CARBOXYLIC ACID TERT BUTYL ESTER;
4 [2 (3 PYRIDIN 4 YLUREIDO)ETHYL]IMIDAZOLE 1 CARBOXYLIC ACID TERT BUTYL ESTER;
4 [3 (AMINO)UREIDO] 1 PYRIDINIUM;
7 [2 (5 AMINO 1,2,4 THIADIAZOL 3 YL) 2 ETHOXYIMINOACETAMIDO] 3 [4 [3 (2 AMINOETHYL)UREIDO]PYRIDINIUM 1 YL]METHYL 3 CEPHEM 4 CARBOXYLATE;
7BETA [2 (5 AMINO 1,2,4 THIADIAZOL 3 YL) 2 ETHOXYIMINOACETAMIDO]CEPHALOSPORIN;
[1 (PYRIDIN 3 YLCARBAMOYL)ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[1 (PYRIDIN 4 YLCARBAMOYL)ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[1 METHYL 2 (3 PYRIDIN 4 YLUREIDO)ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[2 (3 PYRIDIN 4 YLUREIDO)ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[2 (PYRIDIN 4 YLCARBAMOYL)ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[2 (PYRIDIN 4 YLOXY)ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[2 [(PYRIDINE 3 CARBONYL)AMINO]ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[2 [(PYRIDINE 4 CARBONYL)AMINO]ETHYL]CARBAMIC ACID TERT BUTYL ESTER;
[3 (3 PYRIDIN 4 YLUREIDO) 2 TRIETHYLSILANYLOXYPROPYL]CARBAMIC ACID TERT BUTYL ESTER;
[3 (3 PYRIDIN 4 YLUREIDO)PROPYL]CARBAMIC ACID TERT BUTYL ESTER;
CEPHALOSPORIN DERIVATIVE;
METHYL[3 (3 PYRIDIN 4 YLUREIDO)PROPYL]CARBAMIC ACID TERT BUTYL ESTER;
PYRIDIN 4 YLCARBAMIC ACID 2 TERT BUTOXYCARBONYLAMINOETHYL ESTER;
PYRIDINIUM DERIVATIVE;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL STRAIN;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG STRUCTURE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
NONHUMAN;
PSEUDOMONAS AERUGINOSA;
STRUCTURE ANALYSIS;
ANTI-BACTERIAL AGENTS;
CEPHALOSPORINS;
METHICILLIN RESISTANCE;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
PSEUDOMONAS AERUGINOSA;
PYRIDINIUM COMPOUNDS;
STAPHYLOCOCCUS AUREUS;
STRUCTURE-ACTIVITY RELATIONSHIP;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
PSEUDOMONAS;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
|
EID: 3142592640
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2004.05.021 Document Type: Article |
Times cited : (14)
|
References (9)
|